Invention Grant
- Patent Title: Macrocyclic indoles as hepatitis C virus inhibitors
-
Application No.: US13908705Application Date: 2013-06-03
-
Publication No.: US09334282B2Publication Date: 2016-05-10
- Inventor: Pierre Jean-Marie Bernard Raboisson , Lili Hu , Sandrine Marie Helene Vendeville , Origéne Nyanguile , Abdellah Tahri
- Applicant: Janssen R&D Ireland
- Applicant Address: IE Little Island, Co. Cork.
- Assignee: Janssen Sciences Ireland UC
- Current Assignee: Janssen Sciences Ireland UC
- Current Assignee Address: IE Little Island, Co. Cork.
- Agent Andrea Jo Kamage
- Priority: EP07150415 20071224
- Main IPC: A61K31/407
- IPC: A61K31/407 ; C07D487/06 ; C07D487/08 ; C07D513/08 ; C07D513/06
Abstract:
The present invention relates to inhibitors of HCV replication of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, wherein R1; R3; and R4 have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
Public/Granted literature
- US20130267511A1 Macrocyclic Indoles as Hepatitis C Virus Inhibitors Public/Granted day:2013-10-10
Information query
IPC分类:
